Zim Laboratories (NSE:ZIMLAB) Accounts Payable: ₹729 Mil (As of Mar. 2026)


NSE:ZIMLAB Zim Laboratories Ltd NSE:ZIMLAB
80 GF Score
Price ₹124.00
GF Value ₹102.83
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Zim Laboratories Accounts Payable?

Zim Laboratories NSE:ZIMLAB 80 Accounts Payable is ₹729 Mil as of Mar. 2026. GuruFocus rates NSE:ZIMLAB with a GF Score™ of 80/100 and a GF Value™ of ₹102.83 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Zim Laboratories's Accounts Payable for the quarter that ended in Mar. 2026 was ₹729 Mil.

Zim Laboratories's quarterly Accounts Payable declined from Sep. 2025 (₹616 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹729 Mil).

Zim Laboratories's annual Accounts Payable increased from Mar. 2024 (₹624 Mil) to Mar. 2025 (₹695 Mil) and increased from Mar. 2025 (₹695 Mil) to Mar. 2026 (₹729 Mil).

Zim Laboratories Accounts Payable Related Terms

Zim Laboratories Accounts Payable Historical Data

* Premium members only.

The historical data trend for Zim Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim Laboratories Accounts Payable Chart

Zim Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 810.71 582.39 623.81 695.06 729.29

Zim Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 695.06 0.00 615.85 0.00 729.29
NSE:ZIMLAB
80GF Score
Zim Laboratories Ltd NSE:ZIMLAB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zim Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹729 Mil mean?
Zim Laboratories (NSE:ZIMLAB) has a Accounts Payable of ₹729 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zim Laboratories and its competitors.
Is Zim Laboratories' Accounts Payable too high?
Zim Laboratories' current Accounts Payable is ₹729 Mil. Overall, Zim Laboratories has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zim Laboratories' Accounts Payable compare to ZTS and UTHR?
Zim Laboratories' Accounts Payable of ₹729 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zim Laboratories and its competitors. Zim Laboratories's current Accounts Payable is ₹729 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zim Laboratories (NSE:ZIMLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹102.83, compared to a current price of ₹124.00 — trading 20.6% above its estimated fair value. The current Accounts Payable is ₹729 Mil. Zim Laboratories' overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Zim Laboratories (NSE:ZIMLAB), the current Accounts Payable is ₹729 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zim Laboratories (NSE:ZIMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zim Laboratories stock appears to be overvalued. The current stock price of ₹124.00 is trading 20.6% above its estimated GF Value™ of ₹102.83. GuruFocus considers Zim Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:ZIMLAB:

  • Accounts Payable: ₹729 Mil
  • GF Value™: ₹102.83 vs. price of ₹124.00 (20.6% above fair value)
  • GF Score™: 80/100 with 8 warning signs

No single metric tells the full story. See the NSE:ZIMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zim Laboratories Business Description

Other Exchanges 541400:India
Address Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Zim Laboratories Ltd is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. It is engaged in manufacturing &wholesale of pharmaceutical products, market research and research & development activities. The Group is mainly engaged in the business of pharmaceuticals. It has presence in India and Outside India. The company generates majority of revenue from India. Its products are Oral Thin Films, Pre-formulations Intermediates, Finished Formulations.
80GF Score

Get the complete analysis for NSE:ZIMLAB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹124.00
Price
₹102.83
GF Value